1. Home
  2. PTCT vs PHI Comparison

PTCT vs PHI Comparison

Compare PTCT & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • PHI
  • Stock Information
  • Founded
  • PTCT 1998
  • PHI 1928
  • Country
  • PTCT United States
  • PHI Philippines
  • Employees
  • PTCT N/A
  • PHI N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • PHI Telecommunications Equipment
  • Sector
  • PTCT Health Care
  • PHI Telecommunications
  • Exchange
  • PTCT Nasdaq
  • PHI Nasdaq
  • Market Cap
  • PTCT 4.8B
  • PHI 4.1B
  • IPO Year
  • PTCT 2013
  • PHI 1953
  • Fundamental
  • Price
  • PTCT $63.43
  • PHI $19.07
  • Analyst Decision
  • PTCT Buy
  • PHI Hold
  • Analyst Count
  • PTCT 14
  • PHI 1
  • Target Price
  • PTCT $67.00
  • PHI N/A
  • AVG Volume (30 Days)
  • PTCT 1.3M
  • PHI 138.2K
  • Earning Date
  • PTCT 11-06-2025
  • PHI 11-11-2025
  • Dividend Yield
  • PTCT N/A
  • PHI 6.35%
  • EPS Growth
  • PTCT N/A
  • PHI 20.57
  • EPS
  • PTCT 7.72
  • PHI 2.62
  • Revenue
  • PTCT $1,764,929,000.00
  • PHI $3,879,170,293.00
  • Revenue This Year
  • PTCT $119.89
  • PHI $3.27
  • Revenue Next Year
  • PTCT N/A
  • PHI $3.07
  • P/E Ratio
  • PTCT $8.28
  • PHI $7.28
  • Revenue Growth
  • PTCT 96.00
  • PHI 2.02
  • 52 Week Low
  • PTCT $34.57
  • PHI $18.61
  • 52 Week High
  • PTCT $67.40
  • PHI $27.73
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 66.29
  • PHI 38.65
  • Support Level
  • PTCT $57.74
  • PHI $18.69
  • Resistance Level
  • PTCT $67.40
  • PHI $19.08
  • Average True Range (ATR)
  • PTCT 2.31
  • PHI 0.34
  • MACD
  • PTCT 0.16
  • PHI 0.09
  • Stochastic Oscillator
  • PTCT 62.32
  • PHI 34.98

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About PHI PLDT Inc. Sponsored ADR

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

Share on Social Networks: